Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Emergence of NDM-producing Klebsiella pneumoniae and Escherichia coli in Spain: phylogeny, resistome, virulence and plasmids encoding blaNDM-like genes as determined by WGS.

Pérez-Vázquez M, Sola Campoy PJ, Ortega A, Bautista V, Monzón S, Ruiz-Carrascoso G, Mingorance J, González-Barberá EM, Gimeno C, Aracil B, Sáez D, Lara N, Fernández S, González-López JJ, Campos J, Kingsley RA, Dougan G, Oteo-Iglesias J; Spanish NDM Study Group .

J Antimicrob Chemother. 2019 Dec 1;74(12):3489-3496. doi: 10.1093/jac/dkz366.

PMID:
31504589
2.

Characterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016-2017.

Pérez-Vazquez M, Oteo-Iglesias J, Sola-Campoy PJ, Carrizo-Manzoni H, Bautista V, Lara N, Aracil B, Alhambra A, Martínez-Martínez L, Campos J; Spanish Antibiotic Resistance Surveillance Program Collaborating Group.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02529-18. doi: 10.1128/AAC.02529-18. Print 2019 Jun.

3.

Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2.

Arana DM, Ortega A, González-Barberá E, Lara N, Bautista V, Gómez-Ruíz D, Sáez D, Fernández-Romero S, Aracil B, Pérez-Vázquez M, Campos J, Oteo J; Spanish Antibiotic Resistance Surveillance Programme Collaborating Group.

J Antimicrob Chemother. 2017 Dec 1;72(12):3283-3287. doi: 10.1093/jac/dkx325.

PMID:
29029114
4.

The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population.

Esteban-Cantos A, Aracil B, Bautista V, Ortega A, Lara N, Saez D, Fernández-Romero S, Pérez-Vázquez M, Navarro F, Grundmann H, Campos J, Oteo J; EuSCAPE-Spain Network.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02520-16. doi: 10.1128/AAC.02520-16. Print 2017 Apr.

5.

The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3.

Oteo J, Pérez-Vázquez M, Bautista V, Ortega A, Zamarrón P, Saez D, Fernández-Romero S, Lara N, Ramiro R, Aracil B, Campos J; Spanish Antibiotic Resistance Surveillance Program Collaborating Group.

J Antimicrob Chemother. 2016 Dec;71(12):3392-3399. Epub 2016 Aug 15.

6.

Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48.

Ortega A, Sáez D, Bautista V, Fernández-Romero S, Lara N, Aracil B, Pérez-Vázquez M, Campos J, Oteo J; Spanish Collaborating Group for the Antibiotic Resistance Surveillance Programme.

J Antimicrob Chemother. 2016 Aug;71(8):2131-8. doi: 10.1093/jac/dkw148. Epub 2016 May 4.

PMID:
27147304
7.

Phylogeny, resistome and mobile genetic elements of emergent OXA-48 and OXA-245 Klebsiella pneumoniae clones circulating in Spain.

Pérez-Vázquez M, Oteo J, García-Cobos S, Aracil B, Harris SR, Ortega A, Fontanals D, Hernández JM, Solís S, Campos J, Dougan G, Kingsley RA.

J Antimicrob Chemother. 2016 Apr;71(4):887-96. doi: 10.1093/jac/dkv458. Epub 2016 Jan 13.

8.

Rapid Detection of OXA-48-Producing Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Oviaño M, Barba MJ, Fernández B, Ortega A, Aracil B, Oteo J, Campos J, Bou G.

J Clin Microbiol. 2016 Mar;54(3):754-9. doi: 10.1128/JCM.02496-15. Epub 2015 Dec 16.

9.

Rates of faecal colonization by carbapenemase-producing Enterobacteriaceae among patients admitted to ICUs in Spain.

Oteo J, Alcaraz R, Bou G, Conejo C, Díaz-Lamas AM, Fernández-Martínez M, Fontanals D, González-López JJ, López-Contreras J, Martínez-Martínez L, Mora-Rillo M, Muñoz M, Navarro F, Oliver A, Pintado V, Ruiz-Carrascoso G, Ruiz-Garbajosa P, Sánchez-Porto A, Sánchez-Romero I, Zamorano L, Aracil B, Rodríguez-Baño J; Spanish Network for Research in Infectious Diseases (REIPI); GEIH-GEMARA (SEIMC).

J Antimicrob Chemother. 2015 Oct;70(10):2916-8. doi: 10.1093/jac/dkv187. Epub 2015 Jul 9. No abstract available.

PMID:
26163400
10.

Mobile genetic elements related to the diffusion of plasmid-mediated AmpC β-lactamases or carbapenemases from Enterobacteriaceae: findings from a multicenter study in Spain.

Zamorano L, Miró E, Juan C, Gómez L, Bou G, González-López JJ, Martínez-Martínez L, Aracil B, Conejo MC, Oliver A, Navarro F.

Antimicrob Agents Chemother. 2015 Sep;59(9):5260-6. doi: 10.1128/AAC.00562-15. Epub 2015 Jun 15.

11.

Frequent carriage of resistance mechanisms to β-lactams and biofilm formation in Haemophilus influenzae causing treatment failure and recurrent otitis media in young children.

García-Cobos S, Moscoso M, Pumarola F, Arroyo M, Lara N, Pérez-Vázquez M, Aracil B, Oteo J, García E, Campos J.

J Antimicrob Chemother. 2014 Sep;69(9):2394-9. doi: 10.1093/jac/dku158. Epub 2014 Jun 2.

PMID:
24891432
12.

Carbapenemase-producing enterobacteriaceae in Spain in 2012.

Oteo J, Saez D, Bautista V, Fernández-Romero S, Hernández-Molina JM, Pérez-Vázquez M, Aracil B, Campos J; Spanish Collaborating Group for the Antibiotic Resistance Surveillance Program.

Antimicrob Agents Chemother. 2013 Dec;57(12):6344-7. doi: 10.1128/AAC.01513-13. Epub 2013 Sep 16.

13.

Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.

García-Cobos S, Arroyo M, Pérez-Vázquez M, Aracil B, Lara N, Oteo J, Cercenado E, Campos J.

J Antimicrob Chemother. 2014 Jan;69(1):111-6. doi: 10.1093/jac/dkt324. Epub 2013 Aug 13.

PMID:
23943391
14.

Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases.

García-Cobos S, Arroyo M, Campos J, Pérez-Vázquez M, Aracil B, Cercenado E, Orden B, Lara N, Oteo J.

J Antimicrob Chemother. 2013 May;68(5):1054-9. doi: 10.1093/jac/dks525. Epub 2013 Jan 18.

PMID:
23335113
15.

Evaluation of the EUCAST disc diffusion susceptibility testing method for Haemophilus influenzae based on the resistance mechanism to β-lactam antibiotics.

García-Cobos S, Arroyo M, Pérez-Vázquez M, Aracil B, Oteo J, Campos J.

J Antimicrob Chemother. 2013 Jan;68(1):159-63. doi: 10.1093/jac/dks374. Epub 2012 Oct 2.

PMID:
23034712
16.

Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain.

Miró E, Agüero J, Larrosa MN, Fernández A, Conejo MC, Bou G, González-López JJ, Lara N, Martínez-Martínez L, Oliver A, Aracil B, Oteo J, Pascual A, Rodríguez-Baño J, Zamorano L, Navarro F.

Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):253-9. doi: 10.1007/s10096-012-1737-0. Epub 2012 Sep 7. Erratum in: Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):261-2.

PMID:
22956023
17.

Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate.

Pérez-Llarena FJ, Fernández A, Zamorano L, Kerff F, Beceiro A, Aracil B, Cercenado E, Miro E, Oliver A, Oteo J, Navarro F, Bou G.

Antimicrob Agents Chemother. 2012 Aug;56(8):4540-3. doi: 10.1128/AAC.00776-12. Epub 2012 Jun 5.

18.

Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli.

Ortega A, Oteo J, Aranzamendi-Zaldumbide M, Bartolomé RM, Bou G, Cercenado E, Conejo MC, González-López JJ, Marín M, Martínez-Martínez L, Merino M, Navarro F, Oliver A, Pascual A, Rivera A, Rodríguez-Baño J, Weber I, Aracil B, Campos J.

Antimicrob Agents Chemother. 2012 Jul;56(7):3576-81. doi: 10.1128/AAC.06393-11. Epub 2012 Apr 9.

19.

Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases.

Rodríguez-Baño J, Miró E, Villar M, Coelho A, Gozalo M, Borrell N, Bou G, Conejo MC, Pomar V, Aracil B, Larrosa N, Agüero J, Oliver A, Fernández A, Oteo J, Pascual A, Navarro F.

J Infect. 2012 Feb;64(2):176-83. doi: 10.1016/j.jinf.2011.11.016. Epub 2011 Nov 23.

PMID:
22138600
20.

Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid.

Cuevas O, Oteo J, Lázaro E, Aracil B, de Abajo F, García-Cobos S, Ortega A, Campos J; Spanish EARS-Net Study Group.

J Antimicrob Chemother. 2011 Mar;66(3):664-9. doi: 10.1093/jac/dkq471. Epub 2010 Dec 14.

PMID:
21172788
21.

Susceptibility of 228 non-fermenting gram-negative rods to tigecycline and six other antimicrobial drugs.

Gómez-Garcés JL, Aracil B, Gil Y, Burillo A.

J Chemother. 2009 Jun;21(3):267-71.

PMID:
19567346
22.

[Comparison between agar dilution and three other methods for determining the susceptibility of 228 clinical isolates of non-fermenting gram-negative rods].

Gómez-Garcés JL, Aracil B, Gil Y.

Enferm Infecc Microbiol Clin. 2009 Jun;27(6):331-7. doi: 10.1016/j.eimc.2008.10.003. Epub 2009 May 5. Spanish.

PMID:
19406523
23.

Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method.

García-Cobos S, Campos J, Román F, Carrera C, Pérez-Vázquez M, Aracil B, Oteo J.

Antimicrob Agents Chemother. 2008 Jul;52(7):2407-14. doi: 10.1128/AAC.00214-08. Epub 2008 Apr 28.

24.

Trends in antimicrobial resistance in 3469 enterococci isolated from blood (EARSS experience 2001-06, Spain): increasing ampicillin resistance in Enterococcus faecium.

Oteo J, Cuevas O, Navarro C, Aracil B, Campos J; Spanish Group of The European Antimicrobial Resistance Surveillance System (EARSS).

J Antimicrob Chemother. 2007 May;59(5):1044-5. Epub 2007 Mar 21. No abstract available.

PMID:
17376792
25.

Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions.

Oteo J, Navarro C, Cercenado E, Delgado-Iribarren A, Wilhelmi I, Orden B, García C, Miguelañez S, Pérez-Vázquez M, García-Cobos S, Aracil B, Bautista V, Campos J.

J Clin Microbiol. 2006 Jul;44(7):2359-66.

26.

Molecular epidemiology of Haemophilus influenzae type b causing vaccine failures in the United Kingdom.

Aracil B, Slack M, Pérez-Vázquez M, Román F, Ramsay M, Campos J.

J Clin Microbiol. 2006 May;44(5):1645-9.

27.

Limits on the time variation of the electromagnetic fine-structure constant in the low energy limit from absorption lines in the spectra of distant quasars.

Srianand R, Chand H, Petitjean P, Aracil B.

Phys Rev Lett. 2004 Mar 26;92(12):121302. Epub 2004 Mar 26.

PMID:
15089663
28.
29.

Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b.

Campos J, Hernando M, Román F, Pérez-Vázquez M, Aracil B, Oteo J, Lázaro E, de Abajo F; Group of Invasive Haemophilus Infections of the Autonomous Community of Madrid, Spain,.

J Clin Microbiol. 2004 Feb;42(2):524-9.

30.

Antibiotic resistance and clinical significance of Haemophilus influenzae type f.

Campos J, Román F, Pérez-Vázquez M, Aracil B, Oteo J, Cercenado E; Spanish Study Group for H. influenzae type f.

J Antimicrob Chemother. 2003 Dec;52(6):961-6. Epub 2003 Nov 12.

PMID:
14613949
31.

In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.

Pérez-Vázquez M, Román F, Aracil B, Cantón R, Campos J.

Antimicrob Agents Chemother. 2003 Nov;47(11):3539-41.

32.

[Recent increase in vaccine failures due to Haemophilus influenzae serotype b].

Aracil B, Campos J.

Enferm Infecc Microbiol Clin. 2003 Aug-Sep;21(7):384-5. Spanish. No abstract available.

PMID:
14525697
33.

Infections due to Haemophilus influenzae serotype E: microbiological, clinical, and epidemiological features.

Campos J, Román F, Pérez-Vázquez M, Oteo J, Aracil B, Cercenado E; Spanish Study Group for Haemophilus influenzae Type E.

Clin Infect Dis. 2003 Sep 15;37(6):841-5. Epub 2003 Aug 28.

PMID:
12955648
34.
35.

[Sensitivity of Haemophilus influenzae isolates in Spain to 17 oral antibiotics].

Aracil B, Gómez-Garcés JL, Alós JI; Grupo de Estudio de Infección en Atención Primaria de la SEIMC (IAP-SEIMC).

Enferm Infecc Microbiol Clin. 2003 Mar;21(3):131-6. Spanish.

PMID:
12586017
36.

Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.

Alós JI, Aracil B, Oteo J, Gómez-Garcés JL; Spanish Group for the Study of Infection in the Primary Health Care Setting (IAP-SEIMC).

J Antimicrob Chemother. 2003 Feb;51(2):333-7.

PMID:
12562699
37.

Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamides, phenotype patterns and resistance genes.

Aracil B, Miñambres M, Oteo J, De La Rosa M, Gómez-Garcés JL, Alós AJ.

Clin Microbiol Infect. 2002 Nov;8(11):745-8.

38.

Do the quinolones still constitute valid empirical therapy for community-acquired urinary tract infections in Spain?

Oteo J, Aracil B, Hoyo JF, Perianes J, Gómez-Garcés JL, Alós JI.

Clin Microbiol Infect. 1999 Oct;5(10):654-6. doi: 10.1111/j.1469-0691.1999.tb00427.x. No abstract available.

39.

High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria.

Aracil B, Miñambres M, Oteo J, Torres C, Gómez-Garcés JL, Alós JI.

J Antimicrob Chemother. 2001 Oct;48(4):592-4. No abstract available.

PMID:
11581247
41.

Bacteremia by Dermabacter hominis, a rare pathogen.

Gómez-Garcés JL, Oteo J, García G, Aracil B, Alós JI, Funke G.

J Clin Microbiol. 2001 Jun;39(6):2356-7.

42.

[Significant bacteremias by Corynebacterium amycolatum: an emergent pathogen].

Oteo J, Aracil B, Ignacio Alós J, Luis Gómez-Garcés J.

Enferm Infecc Microbiol Clin. 2001 Mar;19(3):103-6. Spanish.

PMID:
11333587
44.

High rate of resistance to nalidixic acid in Salmonella enterica: its role as a marker of resistance to fluoroquinolones.

Oteo J, Aracil B, Alós JI, Gómez-Garcés JL.

Clin Microbiol Infect. 2000 May;6(5):273-6. No abstract available.

45.

High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.

Oteo J, Aracil B, Alós JI, Gómez-Garcés JL.

J Antimicrob Chemother. 2000 May;45(5):691-3.

PMID:
10797095
47.

Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.

Ferrándiz MJ, Oteo J, Aracil B, Gómez-Garcés JL, De La Campa AG.

Antimicrob Agents Chemother. 1999 Oct;43(10):2520-3.

48.

A study of susceptibility of 100 clinical isolates belonging to the Streptococcus milleri group to 16 cephalosporins.

Aracil B, Gomez-Garces JL, Alos JI.

J Antimicrob Chemother. 1999 Mar;43(3):399-402.

PMID:
10223596
49.

[Bacteremia caused by Corynebacterium urealyticum in 2 patients co-infected with HIV and HBV].

Aracil B, Perea B, Barros C, Gómez-Garcés JL.

Enferm Infecc Microbiol Clin. 1997 Mar;15(3):172-3. Spanish. No abstract available.

PMID:
9235067
50.

Morphological identification of alpha-1-antitrypsin in pulmonary macrophages.

Gupta PK, Frost JK, Geddes S, Aracil B, Davidovski F.

Hum Pathol. 1979 May;10(3):345-7.

PMID:
313895

Supplemental Content

Loading ...
Support Center